- Nachrichtendetail
-
06.05.2024 13:56:10 - dpa-AFX: *BMY :OPDIVO + YERVOY GRANTED EMA VALIDATION FOR FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bristol-Myers Squibb Co | 850501 | NYSE | 41,930 | 21.06.24 03:01:23 | +0,890 | +2,17% | 41,820 | 41,980 | 41,260 | 41,930 |
